Add to ORKGWe report very low SARS-CoV-2 seroprevalence in two San Francisco Bay Area populations. Seropositivity was 0.26% in 387 hospitalized patients admitted for non-respiratory indications and 0.1% in 1,000 blood donors. We additionally describe the longitudinal dynamics of immunoglobulin-G, immunoglobulin-M, and in vitro neutralizing antibody titers in COVID-19 patients. Neutralizing antibodies rise in tandem with immunoglobulin levels following symptom onset, exhibiting median time to seroconversion within one day of each other, and there is >93% positive percent agreement between detection of immunoglobulin-G and neutralizing titers
International audienceUnderstanding the immune responses elicited by SARS-CoV-2 infection is critica...
Abstract Background Epidemic projections and public health policies addressing Coronavirus disease (...
BackgroundIt is unknown whether a positive serology result correlates with protective immunity again...
Given the limited availability of serological testing to date, the seroprevalence of SARS-CoV-2-spec...
Understanding antibody-based SARS-CoV-2 immunity is critical for overcoming the COVID-19 pandemic an...
Projections of the stage of the Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) pandemi...
COVID-19 is a pandemic caused by SARS-CoV-2. In Chile, half a million people have been infected and ...
BackgroundSARS-CoV-2 infection can be detected indirectly by measuring the host immune response. For...
BackgroundSARS-CoV-2 infection can be detected indirectly by measuring the host immune response. For...
Antibody responses are important in the control of viral respiratory infection in the human host. Wh...
International audienceIt is of paramount importance to evaluate the prevalence of both asymptomatic ...
We investigated the dynamics of seroconversion in severe acute respiratory syndrome coronavirus 2 (S...
BackgroundTo accurately interpret COVID-19 seroprevalence surveys, knowledge of serum-IgG responses ...
Biobanks are instrumental for accelerating research. Early in SARS-CoV-2 pandemic, the Argentinean B...
International audienceA better understanding of the anti-SARS-CoV-2 immune response is necessary to ...
International audienceUnderstanding the immune responses elicited by SARS-CoV-2 infection is critica...
Abstract Background Epidemic projections and public health policies addressing Coronavirus disease (...
BackgroundIt is unknown whether a positive serology result correlates with protective immunity again...
Given the limited availability of serological testing to date, the seroprevalence of SARS-CoV-2-spec...
Understanding antibody-based SARS-CoV-2 immunity is critical for overcoming the COVID-19 pandemic an...
Projections of the stage of the Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) pandemi...
COVID-19 is a pandemic caused by SARS-CoV-2. In Chile, half a million people have been infected and ...
BackgroundSARS-CoV-2 infection can be detected indirectly by measuring the host immune response. For...
BackgroundSARS-CoV-2 infection can be detected indirectly by measuring the host immune response. For...
Antibody responses are important in the control of viral respiratory infection in the human host. Wh...
International audienceIt is of paramount importance to evaluate the prevalence of both asymptomatic ...
We investigated the dynamics of seroconversion in severe acute respiratory syndrome coronavirus 2 (S...
BackgroundTo accurately interpret COVID-19 seroprevalence surveys, knowledge of serum-IgG responses ...
Biobanks are instrumental for accelerating research. Early in SARS-CoV-2 pandemic, the Argentinean B...
International audienceA better understanding of the anti-SARS-CoV-2 immune response is necessary to ...
International audienceUnderstanding the immune responses elicited by SARS-CoV-2 infection is critica...
Abstract Background Epidemic projections and public health policies addressing Coronavirus disease (...
BackgroundIt is unknown whether a positive serology result correlates with protective immunity again...